Preparation and in vivo evaluation of novel linkers for 211At labeling of proteins-Reference-Cited by-同舟云学术

Preparation and in vivo evaluation of novel linkers for 211At labeling of proteins

Published:2004-11 Issue:8 Volume:31 Page:1061-1071
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Talanov Vladimir S.,Yordanov Alexander T.,Garmestani Kayhan,Milenic Diane E.,Arora Hans C.,Plascjak Paul S.,Eckelman William C.,Waldmann Thomas A.,Brechbiel Martin W.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference56 articles.

1. Therapeutic antibodies: magic bullets hit the target;Gura;Nature,2002

2. Zevalin: 90yttrium labeled anti-CD20 (ibritumomab tiuxetan), a new treatment for non-Hodgkin's lymphoma;Krasner;Curr. Pharm. Biotechnol.,2001

3. New strategies in radioimmunotherapy for lymphoma;Pandit-Taskar;Curr. Oncol. Rep.,2003

4. Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study;Alvarez;Gynecol. Oncol.,1997

5. Radioimmunotherapy of B-cell lymphoma with 131I-anti-B1 (anti-CD20) antibody;Kaminski;N. Engl. J. Med.,1993

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress of astatine-211 in endoradiotherapy: Great advances from fundamental properties to targeted radiopharmaceuticals;Chinese Chemical Letters;2022-07

2. Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer;Nuclear Medicine and Biology;2021-03

3. Radiolabeling chemistry with heavy halogens iodine and astatine;Reference Module in Biomedical Sciences;2021

4. Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer;Journal of Nuclear Medicine;2017-04-27

5. Comparative studies on the therapeutic benefit of targeted α-particle radiation therapy for the treatment of disseminated intraperitoneal disease;Dalton Transactions;2017